INTERNATIONAL PATENT: BLUEPRINT MEDICINES CORPORATION FILES APPLICATION FOR "INTERMEDIATE SALTS FOR SYNTHESIS OF A CDK2 INHIBITOR"

GENEVA, March 11 -- BLUEPRINT MEDICINES CORPORATION (45 Sidney StreetCambridge, Massachusetts 02139) filed a patent application (PCT/US2025/044502) for "INTERMEDIATE SALTS FOR SYNTHESIS OF A CDK2 INHIBITOR" on Sep 02, 2025. With publication no. WO/2026/050766, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Fuhai (No. 388 Haifa Road, Chengdu Cross-Strait Science &Technology Industrial Development Park, WenjiangDistrictChengdu, Sichuan 611130), DE PAOLIS, Omar (45 Sidney StreetCambridge, Massachusetts 02139), KAUFFMAN,...